Obeticholic Acid: A Powerful FXR Agonist for Liver Health and Metabolic Research

Explore the potential of Obeticholic Acid, a key compound in liver disease and metabolic research.

Get a Quote & Sample

Key Advantages

Enhanced FXR Activation

As a potent and selective FXR agonist, Obeticholic Acid provides precise modulation of bile acid homeostasis, making it an indispensable research chemical in metabolic pathway studies.

Therapeutic Potential

Its demonstrated efficacy in treating primary biliary cholangitis and ongoing research into NASH highlight its significant therapeutic potential, driving the demand for high-quality obeticholic acid pharmaceutical chemical.

Research Versatility

The compound's role in liver fibrosis, inflammation, and portal hypertension research makes it a versatile tool for exploring complex biological mechanisms, supporting the need to buy obeticholic acid for various experimental designs.

Key Applications

Primary Biliary Cholangitis (PBC) Research

Investigating Obeticholic Acid's role in managing PBC symptoms and progression provides critical insights for patient care and drug development.

Nonalcoholic Steatohepatitis (NASH) Studies

The compound is a focal point for research into treatments for NASH, aiming to reduce liver fat, inflammation, and fibrosis, thereby supporting its position as a key obeticholic acid for NASH research.

Metabolic Disorder Investigation

Its influence on insulin sensitivity and lipid metabolism makes Obeticholic Acid a valuable agent for understanding and potentially treating metabolic disorders.

Bile Acid Diarrhea Research

Exploring Obeticholic Acid's effects on bile acid malabsorption offers avenues for new treatment strategies for patients suffering from bile acid diarrhea.